Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Petros Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $27.78M | $27.78M - $27.78M | -$10.81M | $0.34 | 1 |
| Dec 2027 | $20.63M | $20.63M - $20.63M | -$8.03M | -$17.50 | 1 |
| Dec 2026 | $11.03M | $11.03M - $11.03M | -$4.29M | -$27.50 | 1 |
| Dec 2025 | $5.47M | $5.47M - $5.47M | -$2.13M | -$27.25 | 1 |
| Dec 2024 | $5.43M | $5.43M - $5.43M | -$2.12M | -$53.25 | 1 |
| Dec 2023 | $7.70M | $7.70M - $7.70M | -$6.08M | -$128.75 | 1 |